Literature DB >> 24272484

Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10.

Bridget Charbonneau1, Matthew S Block, William R Bamlet, Robert A Vierkant, Kimberly R Kalli, Zachary Fogarty, David N Rider, Thomas A Sellers, Shelley S Tworoger, Elizabeth Poole, Harvey A Risch, Helga B Salvesen, Lambertus A Kiemeney, Laura Baglietto, Graham G Giles, Gianluca Severi, Britton Trabert, Nicolas Wentzensen, Georgia Chenevix-Trench, Alice S Whittemore, Weiva Sieh, Jenny Chang-Claude, Elisa V Bandera, Irene Orlow, Kathryn Terry, Marc T Goodman, Pamela J Thompson, Linda S Cook, Mary Anne Rossing, Roberta B Ness, Steven A Narod, Jolanta Kupryjanczyk, Karen Lu, Ralf Butzow, Thilo Dörk, Tanja Pejovic, Ian Campbell, Nhu D Le, Clareann H Bunker, Natalia Bogdanova, Ingo B Runnebaum, Diana Eccles, James Paul, Anna H Wu, Simon A Gayther, Estrid Hogdall, Florian Heitz, Stanley B Kaye, Beth Y Karlan, Hoda Anton-Culver, Jacek Gronwald, Claus K Hogdall, Diether Lambrechts, Peter A Fasching, Usha Menon, Joellen Schildkraut, Celeste Leigh Pearce, Douglas A Levine, Susanne Kruger Kjaer, Daniel Cramer, James M Flanagan, Catherine M Phelan, Robert Brown, Leon F A G Massuger, Honglin Song, Jennifer A Doherty, Camilla Krakstad, Dong Liang, Kunle Odunsi, Andrew Berchuck, Allan Jensen, Jan Lubinski, Heli Nevanlinna, Yukie T Bean, Galina Lurie, Argyrios Ziogas, Christine Walsh, Evelyn Despierre, Louise Brinton, Alexander Hein, Anja Rudolph, Agnieszka Dansonka-Mieszkowska, Sara H Olson, Philipp Harter, Jonathan Tyrer, Allison F Vitonis, Angela Brooks-Wilson, Katja K Aben, Malcolm C Pike, Susan J Ramus, Elisabeth Wik, Cezary Cybulski, Jie Lin, Lara Sucheston, Robert Edwards, Valerie McGuire, Jenny Lester, Andreas du Bois, Lene Lundvall, Shan Wang-Gohrke, Lukasz M Szafron, Sandrina Lambrechts, Hannah Yang, Matthias W Beckmann, Liisa M Pelttari, Anne M Van Altena, David van den Berg, Mari K Halle, Aleksandra Gentry-Maharaj, Ira Schwaab, Urmila Chandran, Janusz Menkiszak, Arif B Ekici, Lynne R Wilkens, Arto Leminen, Francesmary Modugno, Grace Friel, Joseph H Rothstein, Ignace Vergote, Montserrat Garcia-Closas, Michelle A T Hildebrandt, Piotr Sobiczewski, Linda E Kelemen, Paul D P Pharoah, Kirsten Moysich, Keith L Knutson, Julie M Cunningham, Brooke L Fridley, Ellen L Goode.   

Abstract

A missense single-nucleotide polymorphism (SNP) in the immune modulatory gene IL1A has been associated with ovarian cancer risk (rs17561). Although the exact mechanism through which this SNP alters risk of ovarian cancer is not clearly understood, rs17561 has also been associated with risk of endometriosis, an epidemiologic risk factor for ovarian cancer. Interleukin-1α (IL1A) is both regulated by and able to activate NF-κB, a transcription factor family that induces transcription of many proinflammatory genes and may be an important mediator in carcinogenesis. We therefore tagged SNPs in more than 200 genes in the NF-κB pathway for a total of 2,282 SNPs (including rs17561) for genotype analysis of 15,604 cases of ovarian cancer in patients of European descent, including 6,179 of high-grade serous (HGS), 2,100 endometrioid, 1,591 mucinous, 1,034 clear cell, and 1,016 low-grade serous, including 23,235 control cases spanning 40 studies in the Ovarian Cancer Association Consortium. In this large population, we confirmed the association between rs17561 and clear cell ovarian cancer [OR, 0.84; 95% confidence interval (CI), 0.76-0.93; P = 0.00075], which remained intact even after excluding participants in the prior study (OR, 0.85; 95% CI, 0.75-0.95; P = 0.006). Considering a multiple-testing-corrected significance threshold of P < 2.5 × 10(-5), only one other variant, the TNFSF10 SNP rs6785617, was associated significantly with a risk of ovarian cancer (low malignant potential tumors OR, 0.85; 95% CI, 0.79-0.91; P = 0.00002). Our results extend the evidence that borderline tumors may have a distinct genetic etiology. Further investigation of how these SNPs might modify ovarian cancer associations with other inflammation-related risk factors is warranted.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24272484      PMCID: PMC3946482          DOI: 10.1158/0008-5472.CAN-13-1051

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  52 in total

1.  CARD11 mediates factor-specific activation of NF-kappaB by the T cell receptor complex.

Authors:  Joel L Pomerantz; Elissa M Denny; David Baltimore
Journal:  EMBO J       Date:  2002-10-01       Impact factor: 11.598

Review 2.  Nuclear factor-kappaB: a main regulator of inflammation and cell survival in endometriosis pathophysiology.

Authors:  Reinaldo González-Ramos; Sylvie Defrère; Luigi Devoto
Journal:  Fertil Steril       Date:  2012-07-06       Impact factor: 7.329

3.  PLINK: a tool set for whole-genome association and population-based linkage analyses.

Authors:  Shaun Purcell; Benjamin Neale; Kathe Todd-Brown; Lori Thomas; Manuel A R Ferreira; David Bender; Julian Maller; Pamela Sklar; Paul I W de Bakker; Mark J Daly; Pak C Sham
Journal:  Am J Hum Genet       Date:  2007-07-25       Impact factor: 11.025

4.  GenoSNP: a variational Bayes within-sample SNP genotyping algorithm that does not require a reference population.

Authors:  Eleni Giannoulatou; Christopher Yau; Stefano Colella; Jiannis Ragoussis; Christopher C Holmes
Journal:  Bioinformatics       Date:  2008-07-24       Impact factor: 6.937

5.  IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer.

Authors:  Florian R Greten; Lars Eckmann; Tim F Greten; Jin Mo Park; Zhi-Wei Li; Laurence J Egan; Martin F Kagnoff; Michael Karin
Journal:  Cell       Date:  2004-08-06       Impact factor: 41.582

6.  The MAGUK family protein CARD11 is essential for lymphocyte activation.

Authors:  Hiromitsu Hara; Teiji Wada; Chris Bakal; Ivona Kozieradzki; Shinobu Suzuki; Nobutaka Suzuki; Mai Nghiem; Emily K Griffiths; Connie Krawczyk; Birgit Bauer; Fulvio D'Acquisto; Sankar Ghosh; Wen Chen Yeh; Gottfried Baier; Robert Rottapel; Josef M Penninger
Journal:  Immunity       Date:  2003-06       Impact factor: 31.745

7.  Transactivation of the interleukin-1alpha promoter by human T-cell leukemia virus type I and type II Tax proteins.

Authors:  N Mori; D Prager
Journal:  Blood       Date:  1996-04-15       Impact factor: 22.113

8.  Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium.

Authors:  Britton Trabert; Roberta B Ness; Wei-Hsuan Lo-Ciganic; Megan A Murphy; Ellen L Goode; Elizabeth M Poole; Louise A Brinton; Penelope M Webb; Christina M Nagle; Susan J Jordan; Harvey A Risch; Mary Anne Rossing; Jennifer A Doherty; Marc T Goodman; Galina Lurie; Susanne K Kjær; Estrid Hogdall; Allan Jensen; Daniel W Cramer; Kathryn L Terry; Allison Vitonis; Elisa V Bandera; Sara Olson; Melony G King; Urmila Chandran; Hoda Anton-Culver; Argyrios Ziogas; Usha Menon; Simon A Gayther; Susan J Ramus; Aleksandra Gentry-Maharaj; Anna H Wu; Celeste Leigh Pearce; Malcolm C Pike; Andrew Berchuck; Joellen M Schildkraut; Nicolas Wentzensen
Journal:  J Natl Cancer Inst       Date:  2014-02       Impact factor: 11.816

9.  PKC beta regulates BCR-mediated IKK activation by facilitating the interaction between TAK1 and CARMA1.

Authors:  Hisaaki Shinohara; Tomoharu Yasuda; Yuichi Aiba; Hideki Sanjo; Megumi Hamadate; Hiroshi Watarai; Hiroaki Sakurai; Tomohiro Kurosaki
Journal:  J Exp Med       Date:  2005-11-21       Impact factor: 14.307

10.  A genotype calling algorithm for the Illumina BeadArray platform.

Authors:  Yik Y Teo; Michael Inouye; Kerrin S Small; Rhian Gwilliam; Panagiotis Deloukas; Dominic P Kwiatkowski; Taane G Clark
Journal:  Bioinformatics       Date:  2007-09-10       Impact factor: 6.937

View more
  23 in total

Review 1.  Interleukin 1α and the inflammatory process.

Authors:  Nelson C Di Paolo; Dmitry M Shayakhmetov
Journal:  Nat Immunol       Date:  2016-07-19       Impact factor: 25.606

2.  Pre-diagnostic serum levels of inflammation markers and risk of ovarian cancer in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial.

Authors:  Britton Trabert; Ligia Pinto; Patricia Hartge; Troy Kemp; Amanda Black; Mark E Sherman; Louise A Brinton; Ruth M Pfeiffer; Meredith S Shiels; Anil K Chaturvedi; Allan Hildesheim; Nicolas Wentzensen
Journal:  Gynecol Oncol       Date:  2014-08-23       Impact factor: 5.482

Review 3.  Targeted immune therapy of ovarian cancer.

Authors:  Keith L Knutson; Lavakumar Karyampudi; Purushottam Lamichhane; Claudia Preston
Journal:  Cancer Metastasis Rev       Date:  2015-03       Impact factor: 9.264

4.  Immune suppressive function of IL-1α release in the tumor microenvironment regulated by calpain 1.

Authors:  Dandan Lin; Yu Mei; Lei Lei; Zuhairah Binte Hanafi; Ziqi Jin; Yonghao Liu; Yuan Song; Yinsheng Zhang; Bo Hu; Chunliang Liu; Jinhua Lu; Haiyan Liu
Journal:  Oncoimmunology       Date:  2022-06-15       Impact factor: 7.723

5.  Identifying the genes regulated by IDH1 via gene-chip in glioma cell U87.

Authors:  Jie Ren; Meiqing Lou; Jinlong Shi; Yajun Xue; Daming Cui
Journal:  Int J Clin Exp Med       Date:  2015-10-15

6.  Targetable Immune Regulatory Molecule Expression in High-Grade Serous Ovarian Carcinomas in African American Women: A Study of PD-L1 and IDO in 112 Cases From the African American Cancer Epidemiology Study (AACES).

Authors:  Anne M Mills; Lauren C Peres; Alice Meiss; Kari L Ring; Susan C Modesitt; Sarah E Abbott; Anthony J Alberg; Elisa V Bandera; Jill Barnholtz-Sloan; Melissa L Bondy; Michele L Cote; Ellen Funkhouser; Patricia G Moorman; Edward S Peters; Ann G Schwartz; Paul D Terry; Kristin Wallace; Joellen M Schildkraut
Journal:  Int J Gynecol Pathol       Date:  2019-03       Impact factor: 2.762

7.  Multilevel analysis of neuropathogenesis of neurocognitive impairment in HIV.

Authors:  Andrew J Levine; Virawudh Soontornniyomkij; Cristian L Achim; Eliezer Masliah; Benjamin B Gelman; Janet S Sinsheimer; Elyse J Singer; David J Moore
Journal:  J Neurovirol       Date:  2015-12-04       Impact factor: 2.643

Review 8.  Molecular Pathways: The Balance between Cancer and the Immune System Challenges the Therapeutic Specificity of Targeting Nuclear Factor-κB Signaling for Cancer Treatment.

Authors:  Kristen P Zeligs; Monica K Neuman; Christina M Annunziata
Journal:  Clin Cancer Res       Date:  2016-07-15       Impact factor: 12.531

Review 9.  Function and regulation of IL-1α in inflammatory diseases and cancer.

Authors:  Ankit Malik; Thirumala-Devi Kanneganti
Journal:  Immunol Rev       Date:  2018-01       Impact factor: 12.988

10.  A targeted genetic association study of epithelial ovarian cancer susceptibility.

Authors:  Madalene Earp; Stacey J Winham; Nicholas Larson; Jennifer B Permuth; Hugues Sicotte; Jeremy Chien; Hoda Anton-Culver; Elisa V Bandera; Andrew Berchuck; Linda S Cook; Daniel Cramer; Jennifer A Doherty; Marc T Goodman; Douglas A Levine; Alvaro N A Monteiro; Roberta B Ness; Celeste L Pearce; Mary Anne Rossing; Shelley S Tworoger; Nicolas Wentzensen; Maria Bisogna; Louise Brinton; Angela Brooks-Wilson; Michael E Carney; Julie M Cunningham; Robert P Edwards; Zachary C Fogarty; Edwin S Iversen; Peter Kraft; Melissa C Larson; Nhu D Le; Hui-Yi Lin; Jolanta Lissowska; Francesmary Modugno; Kirsten B Moysich; Sara H Olson; Malcolm C Pike; Elizabeth M Poole; David N Rider; Kathryn L Terry; Pamela J Thompson; David van den Berg; Robert A Vierkant; Allison F Vitonis; Lynne R Wilkens; Anna H Wu; Hannah P Yang; Argyrios Ziogas; Catherine M Phelan; Joellen M Schildkraut; Yian Ann Chen; Thomas A Sellers; Brooke L Fridley; Ellen L Goode
Journal:  Oncotarget       Date:  2016-02-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.